Schering Intron-A, Rebetron Promotions Under Investigation
Executive Summary
Schering-Plough is responding to two federal grand jury subpoenas regarding promotional practices for the interferon brands Intron A and Rebetron, the company disclosed in its Nov. 12 10-Q filing
You may also be interested in...
Schering Sets Aside $150 Mil. For Liabilities In Marketing Investigations
Schering-Plough is estimating its "minimum liability" in pending investigations of its marketing practices at the low end of recent settlements within the pharmaceutical industry
Schering Sets Aside $150 Mil. For Liabilities In Marketing Investigations
Schering-Plough is estimating its "minimum liability" in pending investigations of its marketing practices at the low end of recent settlements within the pharmaceutical industry
Serostim Off-Label Use Under Scrutiny; Prosecutor Looks At Job Descriptions
The Boston U.S. Attorney's Office may be looking at employee job descriptions or performance criteria in its investigations of off-label promotion